drugset / Trial / NCT00330200
Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to examine the effects of ISIS 113715 monotherapy on insulin sensitivity, glucose and lipid metabolism and energy expenditure in subjects with type 2 diabetes mellitus.
Timeline
- Start
- 2005-11-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
Outcome
Outcome not reported
Stopped (Enrollment): “Due to poor enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ISIS 113715 | Antisense oligonucleotide | — | — |